Regenerative Medical Technology RMTG
OTC RMTG
$0.04 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Acquisitions (2020 - 2021)

Updated

Regenerative Medical Technology (RMTG) recorded Acquisitions of -$180.00 in Q4 2021.

Analysis

Regenerative Medical Technology (RMTG) Acquisitions (2020 - 2021) Analysis & Trends

For FY2021, Regenerative Medical Technology reported Acquisitions of $666,467, up 280.8% from FY2020.

  • Across earlier years, Acquisitions came in at $175,000 in FY2020.
  • The Q4 2021 figure is the highest quarterly Acquisitions since Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Regenerative Medical Technology 549,558.71 -3.98 Mn 2.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -174,820.00
Sep 30, 2021 -741,647.00
Sep 30, 2020 125,000.00
API Access

Regenerative Medical Technology Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RMTG&period=max&api_key=YOUR_API_KEY